Welcome to STP
Society of Toxicologic Pathology Vision and four primary goals:
advocacy, education, globalization, and recruitment.
About STP | What Is Toxicologic Pathology? | STP Strategic Plan
A new INHAND Soft Tissue and Integument supplement published in the Journal of Toxicologic Pathology is now available online.
Proliferative and Non-Proliferative Lesions of the Rat and Mouse Soft Tissue, Skeletal Muscle and Mesothelium
Proliferative and Non-Proliferative Lesions of the Rat and Mouse Integument
A new issue of Toxicologic Pathology (Volume 42 Number 6) is now available online. (Member login required)
STP Webinar: Toxicology of Major Drug Classes used in Human Medicine—July 31, 11:45 AM EDT
The STP will host a webinar on July 31 at 11:45 AM ET/10:45 CT (1 hour) from the Midwest Association of Veterinary Pathologists (MAVP) annual meeting in Madison, Wisconsin, by Dr. Brett Saladino. There is no charge for attending this meeting or participating in the webinar, however, webinar registration is required.
STP Webinar: Bone Marrow Evaluation in Nonclinical Toxicology Studies—August 7, 10:30 AM EDT
The International Subcommittee of the STP Education Committee proudly announces a webinar for STP India based on their interest in the topic of “Bone Marrow Evaluation in Nonclinical Toxicology Studies.” Presentations will be delivered by Dr. William (Bill) Reagan and Dr. Kay Criswell. This webinar is open to all STP members. There is no fee to attend, however, webinar registration is required.
Toxicologic Pathology 2013 Best Paper Award
Unexpected Thrombocytopenia and Anemia in Cynomolgus Monkeys Induced by a Therapeutic Human
Toxicol Pathol, 2013; 41(7): pp. 951-969, originally published online March 7, 2013. (Member login required)
INHAND: New INHAND Working Group to Review Apoptosis and Necrosis Terminology
Four New Webinar Recordings are now available:
(Member login required)
ACT Webinar on Safety Testing of Metabolites—Co-sponsored by STP (May 21)
Pathology Challenges of Juvenile Toxicity Studies (May 9)
Tox21: A US Federal Collaboration to Improve the Human Hazard Characterization of Chemicals (April 23)
Tox21: Using Unsupervised Pattern Analysis to Hypothesize Chemical Effects In Biological Systems (April 23)
The Spring 2014 Issue of the SCOPE Newsletter is now available!
SEND Presentation: Requirements for Standardized Study Data: Update on Guidance
Member Input Requested by June 13: STP Draft Position Paper on Recommended (“Best”) Practices for Defining and Communicating Adversity for Nonclinical Study Data (Member login required.)
New CE Course Recordings, Keynote Address Online
Three half-day courses and the keynote from the June 2013 Annual Symposium are now available online for member audio/visual viewing. Inflammatory Biomarkers, Immunogenicity/Hypersensitivity of Biologics, and Environmental Toxicologic Pathology can be accessed on the Web Education section. Gut Microbiota, Low-Grade Inflammation and the Metabolic Syndrome, the keynote address presented by Dr. Andrew Gewirtz, is also available.
STP Position Paper: Interpreting the Significance of Increased Alveolar Macrophages in Rodents Following Inhalation of Pharmaceutical Materials
Nonneoplastic Lesion Atlas—The National Toxicology Program (NTP) has created a new web-based resource containing thousands of high quality images and guidelines for diagnosis of nonneoplastic lesions in experimental rodent models. The first nine sections are now available the NTP website. When completed, the Atlas will contain 56 sections, each focusing on a particular organ or tissue.
Related article in February issue of Toxicologic Pathology.
Announcing INHAND Nomenclature Change Control
The INHAND Project (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions) is a joint initiative of the STP, ESTP, BSTP and JSTP to develop an internationally-accepted nomenclature for proliferative and non-proliferative lesions in laboratory animals. The INHAND nomenclature is being adopted by the US FDA for use in the SEND initiative (Standard for the Exchange of Nonclinical Data). Pathologists who discover a lesion in a toxicity study that is not covered by the INHAND nomenclature are encouraged to request a new INHAND term. In addition, changes, additions, and updates to current terms may be desirable and may be requested.
Best Practices for Veterinary Toxicologic Clinical Pathology,
with Emphasis on the Pharmaceutical and Biotechnology Industries (DOI: 10.1111/vcp.12059).
Are you unfamiliar with ToxPathNet? STP members can now use a link on the ToxPathNet homepage to view a 3-minute slide show to learn how to navigate this area of the website. (Member login required.)
Navigating the STP Website
A 3-minute slide show is now available to assist in learning to navigate the website. (Select the button on the left to access.)
The Role of the Toxicologic Pathologist in the Biopharmaceutical Industry
As part of an STP initiative to provide awareness of the specialized role of toxicologic pathologists in the biopharmaceutical industry, a review paper was published in the International Journal of Toxicology to educate and to attract new scientists and veterinarians to the field.
*This CE course meets the requirements for 3.5 hours of continuing education as a noninteractive online program, as well as seminar/lecture in jurisdictions which recognize AAVSB’s RACE approval; however participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. AAVSB RACE Provider #56.